Korea University College of Medicine Reports Findings in Multiple Myeloma (Real-World Experience of Weekly Carfilzomib in Combination with Cyclophosphamide and Dexamethasone in Multiple Myeloma Relapsed/Refractory to Bortezomib and Lenalidomide)

Press/Media: Press / Media

Period2025 May 13

Media coverage

1

Media coverage